LakeShore Biopharma Co., Ltd. Quarterly Retained Earnings (Accumulated Deficit) in CNY from Q1 2022 to Q1 2024

Taxonomy & unit
us-gaap: CNY and USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
LakeShore Biopharma Co., Ltd. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q1 2022 to Q1 2024.
  • LakeShore Biopharma Co., Ltd. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -¥2.31B, a 23.1% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (CNY)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.